拓新药业 (301089.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(拓新药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 108,322,506.68835,509,951.28746,127,863.80656,976,189.03551,007,175.69784,722,063.54422,920,517.10246,646,461.97129,549,459.57
 营业利润(元) 2,476,875.18321,683,932.11381,896,140.21397,619,903.88401,191,562.23329,291,632.52128,739,862.3656,986,444.7335,508,297.12
 利润总额(元) 2,452,205.56316,533,369.79379,615,109.46395,584,307.29399,504,808.45325,269,786.45127,549,764.1856,123,390.0235,085,124.14
 净利润(元) 2,068,381.83243,072,734.38313,190,833.52309,532,944.12304,306,229.57286,535,459.93109,484,923.3554,056,610.8028,439,239.02
 归属于母公司股东的净利润(元) 2,068,381.83243,072,734.38313,190,833.52309,532,944.12304,306,229.57286,535,459.93109,484,923.3554,056,610.8028,439,239.02
盈利能力:
 销售毛利率(%) 26.1657.8869.7575.4382.7460.1145.8440.2344.09
 销售净利率(%) 1.9129.0941.9847.1155.2336.5125.8921.9221.95
 净资产收益率(%) 0.1316.3221.8622.1421.59----
 总资产报酬率ROA(%) 0.0917.0122.4223.3223.25----
 投入资本回报率ROIC(%) 0.1315.5819.6219.4618.7421.158.564.252.29
营运能力:
 存货周转率(次) 0.361.580.910.660.42----
 应收账款周转率(次) 0.708.636.495.184.32----
 总资产周转率(次) 0.060.450.440.390.32----
偿债能力:
 资产负债率(%) 11.7412.8210.2012.2916.7525.3320.4723.3219.64
 股东权益比率(%) 88.2687.1889.8087.7183.2574.6779.5376.6880.36
 已获利息倍数(倍) -2.36-93.14-138.70-187.18-1,934.22-110.79-39.02-22.17-67.97
 流动比率 4.564.236.135.163.942.393.132.763.38
 速动比率 3.393.144.323.783.011.802.161.942.47
发展能力:
 营业收入增长率(%) -80.346.4776.42166.36325.3356.178.88-13.16-10.22
 营业利润增长率(%) -99.38-2.31196.64597.741,029.85315.5463.19-11.26-3.19
 税后利润增长率(%) -99.32-15.17186.06472.61970.02336.0566.171.34-5.57
 净资产增长率(%) -5.1716.4940.0945.5750.3625.43114.28109.13115.89
 总资产增长率(%) -10.55-0.2324.0727.2745.1432.2660.4459.6850.08

前瞻产业研究院